Halloysite clay nanotubes as carriers for curcumin: Characterization and application

IEEE Transactions on Nanotechnology

Volumn 15, Issue 5, 2017, Pages 720-724

  Dionisi, Chiara ^a,b   Hanafy, Nemany ^b,c   Nobile, Concetta ^b   De Giorgi, Maria Luisa ^c   Rinaldi, Ross ^c   Casciaro, Sergio ^d   Lvov, Yuri M ^e   Leporatti, Stefano ^b  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SALENTO   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e LOUISIANA TECH UNIVERSITY   (United States)

Author keywords

Biocompatibility; curcumin; cytotoxicity; drug release; halloysite nanotubes

Indexed keywords

BIOCOMPATIBILITY; CELLS; CYTOTOXICITY; DISEASES; KAOLINITE; MEDICAL IMAGING; NANOTUBES; POLYELECTROLYTES; POLYMERS; YARN;

BREAST CANCER CELLS; CONFOCAL LASER SCANNING MICROSCOPY; CURCUMIN; DRUG RELEASE; HALLOYSITE NANOTUBES; PHARMACOLOGICAL ACTIVITY; SOLUBILITY IN WATERS; TUBULAR STRUCTURES;

PLASTIC COATINGS;

EID: 84987842659     PISSN: 1536125X     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNANO.2016.2524072     Document Type: Article

References (11)

1. R. Price, B. Gaber, and Y. Lvov, "Release characteristics of tetracycline, khellin and NAD from halloysite: A cylindrical mineral for delivery of biologically active agents," J. Microencapsulation, vol. 18, pp. 713-723, 2001.
2. Y. Lvov, D. Shchukin, H. Mohwald, and R. Price, "Clay nanotubes for controlled release of protective agents," ACS Nano, vol. 2, pp. 814-820, 2008.
3. V. Vergaro, Y. M. Lvov, and S. Leporatti, "Halloysite clay nanotubes for resveratrol delivery to cancer cells," Macromol. Biosci., vol. 12, no. 9, pp. 1265-1271, 2012.
4. G. Soloperto, F. Conversano, A. Greco, E. Casciaro, A. Ragusa, S. Leporatti, A. Lay-Ekuakille, and S. Casciaro, "Multiparametric evaluation of the acoustic behaviour of halloysite nanotubes for medical echographic image enhancement," IEEE Trans. Instrum. Meas., vol. 63, no. 6, pp. 1423-1430, Jun. 2014.
5. V. Vergaro, E. Abdullayev, Y. M. Lvov, A. Zeitoun, R. Cingolani, R. Rinaldi, and S. Leporatti, "Cytocompatibility and uptake of halloysite clay nanotubes," Biomacromolecules, vol. 11, pp. 820-826, 2010.
6. X. Lai, M. Agarwal, Y. M. Lvov, C. Pachpande, K. Varahramyan, and F. A.Witzmann, "Proteomic profiling of halloysite caly nanotube exposure in intestinal cell co-culture," J. Appl. Toxicol., vol. 33, no. 11, pp. 1316-1329, 2013.
7. G. I. Fakhrullina, F. S. Akhatova, Y. M. Lvov, and R. F. Fakhrulin, "Toxicity of halloysite clay nanotube in vivo: A Caenorhabditis elegans study," Environ. Sci. Nano, vol. 2, pp. 54-59, 2015.
8. S. Shishodia, G. Sethi, and B. B. Aggarwal, "Curcumin: Getting back to the roots," Ann. New York Acad. Sci., vol. 1056, no. 1, pp. 206-217, 2005.
9. M. Fang, Y. Jin, W. Bao, H. Gao, M. Xu, D. Wang, X. Wang, P. Yao, and L. Liu, "In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration," Int. J. Nanomedicine, vol. 7, pp. 5395-404, 2012.
10. N. G. Veerabadran, D. Mongayt, V. Torchilin, R. R. Price, and Y. M. Lvov, "Organised shells on caly nanotubes for controlled releasd ofmacromolecules," Macromol. Rapid Commun., vol. 30, pp. 99-103, 2009.
11. F. Chiriaco, F. Conversano, E. A. Sbenaglia, and S.Casciaro, "Cytotoxicity measurements of halloysite nanotubes for nanomedicine applications," in Proc. IEEE Int. Symp. Med. Meas. Appl., 2014, pp. 564-567.